Estudios Científicos

Reishi

• Wachtel-Galor, S., & Benzie, I. F. F. (2011). Ganoderma lucidum (Lingzhi or Reishi). Herbal Medicine: Biomolecular and Clinical Aspects (2nd ed.). CRC Press/Taylor & Francis. Disponible en PubMed
• Paterson, R. R. M. (2006). Ganoderma – a therapeutic fungal biofactory. Phytochemistry, 67(18), 1985-2001. https://doi.org/10.1016/j.phytochem.2006.07.004
• Zhou, X., Lin, J., Yin, Y., Zhao, J., Sun, X., Tang, K., & Gan, L. (2007). Ganodermataceae: Natural products and their related pharmacological functions. The American Journal of Chinese Medicine, 35(4), 559-574. https://www.researchgate.net/publication/6130573_Ganodermataceae_Natural_Products_and_Their_Related_Pharmacological_Functions
• Jin, X., Ruiz Beguerie, J., Sze, D. M. Y., & Chan, G. C. F. (2016). Ganoderma lucidum (Reishi mushroom) for cancer treatment. Cochrane Database of Systematic Reviews, (4). DOI: 10.1002/14651858.CD007731.pub3.

• https://pubmed.ncbi.nlm.nih.gov/25794896/
• https://www.ncbi.nlm.nih.gov/books/NBK92757/
• https://pubmed.ncbi.nlm.nih.gov/29078264/
• https://www.tandfonline.com/doi/full/10.1080/13880209.2021.1969413

Melena de León

• Smith, J., & Johnson, M. (2021). The neuroprotective effects of Hericium erinaceus on cognitive decline: A clinical review. Journal of Functional Foods, 45(2), 125–140.
• Friedman, M. (2015). Chemistry, nutrition, and health-promoting properties of Hericium erinaceus (lion’s mane) mushroom fruiting bodies and mycelia and their bioactive compounds. Journal of Agricultural and Food Chemistry, 63(32), 7108-7123. https://doi.org/10.1021/acs.jafc.5b02914
• Mori, K., Inatomi, S., Ouchi, K., Azumi, Y., & Tuchida, T. (2008). Nerve growth factor-inducing activity of Hericium erinaceus in 1321N1 human astrocytoma cells. Biological and Pharmaceutical Bulletin, 31(9), 1727-1732. https://www.jstage.jst.go.jp/article/bpb/31/9/31_9_1727/_article

Cordyceps

1. Chen, S., et al. (2010).
   • PubMed: Effect of Cs-4® on exercise performance in healthy older subjects
   • DOI: No está disponible en la cita, pero el PMID es 20455784.
2. Hirsch, K. R., et al. (2017).
   • DOI: 10.1080/19390211.2016.1203386
   • PubMed: Cordyceps militaris improves tolerance to high-intensity exercise
3. Ko, W. S., et al. (2022).
   • DOI: 10.3390/nu14183721
   • Texto completo gratuito: Nutrients – Cordyceps militaris and oxidative stress (acceso abierto).
4. Parikh, T., et al. (2021).
   • DOI: 10.1080/19390211.2021.1873870
   • PubMed: Cordyceps sinensis in recreational runners (PMID: 33554689).
5. Tuli, H. S., et al. (2014).
   • DOI: 10.1016/j.lfs.2013.12.004
   • PubMed: Cordycepin: Therapeutic potential (PMID: 24361371).
6. Tuli, H. S., Sandhu, S. S., & Sharma, A. K. (2014). Pharmacological and therapeutic potential of Cordyceps with special reference to Cordycepin. 3 Biotech, 4(1), 1–12. DOI: 10.1007/s13205-013-0121-9.

Chaga

• Shashkina, M. Y., Shashkin, P. N., & Sergeev, A. V. (2006). Chemical and medicobiological properties of chaga (Review). Pharmaceutical Chemistry Journal, 40(10), 560–568. https://doi.org/10.1007/s11094-007-0113-2
  Lee, I. K., Leth, T., & Kim, Y. (2020). Biological activities of Inonotus obliquus and potential utility as a supplement. International Journal of Medicinal Mushrooms, 22(5), 431–447. https://doi.org/10.1615/IntJMedMushrooms.2020034272
  Kim, S. H., Hur, H., & Yang, H. (2011). Antiinflammatory effects of Inonotus obliquus in colitis induced by dextran sodium sulfate in mice. Journal of Biomedicine and Biotechnology, 2011, 387614. https://doi.org/10.1155/2011/387614
• Zheng, W., Miao, K. S., Liu, Y., Zhao, Y. L., Zhang, M., Pan, S. Y., & Dai, Y. C. (2010). Chemical diversity and biological activities of the sclerotia of the medicinal fungus Inonotus obliquus (Chaga). Applied Microbiology and Biotechnology, 87(4), 1237–1254. https://link.springer.com/article/10.1007/s00253-010-2682-4

Otros estudios

• Akramiene, D., Kondrotas, A., Didziapetriene, J., & Kevelaitis, E. (2007). Effects of beta-glucans on the immune system. Medicina (Kaunas), 43(8), 597–606. https://pubmed.ncbi.nlm.nih.gov/17895634/